INOVIO PHARMACEUTICALS, INC. (INO) › Capital ExpendituresINOVIO PHARMACEUTICALS, INC. (INO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $48.4K2010: $181.6K2011: $161.2K2012: $241.0K2013: $176.9K2014: $1.38M2015: $2.78M2016: $2.74M2017: $10.29M2018: $2.09M2019: $987.9K2020: $1.52M2021: $1.23M2022: $969.2K2023: $320.9K2024: $487.8K2025: $285.7K$285.7K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$285.7K-41.4%2024$487.8K+52.0%2023$320.9K-66.9%2022$969.2K-21.3%2021$1.23M-19.0%2020$1.52M+53.9%2019$987.9K-52.6%2018$2.09M-79.7%2017$10.29M+275.9%2016$2.74M-1.5%2015$2.78M+101.6%2014$1.38M+680.0%2013$176.9K-26.6%2012$241.0K+49.5%2011$161.2K-11.3%2010$181.6K+275.6%2009$48.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share